MILWAUKEE, Aug. 2, 2023 /PRNewswire/ -- Ademi LLP is investigating EQRx (Nasdaq:EQRX) for possible breaches of fiduciary duty and other violations of law in its transaction with Revolution Medicines.
Read more at prnewswire.comShareholder Alert: Ademi LLP investigates whether EQRx, Inc. has obtained a Fair Price in its transaction with Revolution Medicines
PR Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
/Computer%20board%20micro%20chip%20green%20by%20blickpixel%20via%20Pixabay.jpg){kind=tracking}
